These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 19672233)

  • 1. [New technologies of neurometabolic therapy of cerebrovascular diseases].
    Penionzhkevich DIu; Gorbunov FE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(7):19-22. PubMed ID: 19672233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intranasal electrophoresis using a neurotropic preparation as a promising technique for the rehabilitative treatment of patients with cerebrovascular diseases].
    Penionzhkevich DIu; Peregonchaia OV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2009; (3):3-8. PubMed ID: 19639690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The application of combined physiotherapeutic methods for the complex treatment of patients with dyscirculatory encephalopathy].
    Shiman AG; Klocheva EG; Kaiumov SF; Shoferova SD; Zhukova MV
    Vopr Kurortol Fizioter Lech Fiz Kult; 2012; (2):9-12. PubMed ID: 22908466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The assessment of the clinical efficacy, vasoactive and metabolic effects of mexidol in elderly patients with discirculatory encephalopathy].
    Abramenko IuV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(11 Pt 1):35-41. PubMed ID: 22611676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Craniospinal electromagnetic therapy in the neurological practice].
    Voropaev AA; Troshin VD; Mochalov AD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(12):16-20. PubMed ID: 18427454
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Complex therapy of acute and exacerbated chronic nonspecific parotitis including mexidol and non-coherent infrared therapy].
    Deriabin EI; Shumikhina LA
    Stomatologiia (Mosk); 2006; 85(3):21-3. PubMed ID: 16858317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The use of mexidol in psychiatric practice].
    Kosenko VG; Karagezian EA; Luneva LV; Smolenko LF
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(6):38-41. PubMed ID: 16841482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transcranial electrostimulation in chronic cerebral vascular insufficiency].
    Voropaev AA; Mochalov AD
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(5):31-4. PubMed ID: 16768222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chronic cerebrovascular diseases associated with metabolic syndrome: new treatment approaches].
    Tanashian MM; Lagoda OV; Antonova KV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):21-6. PubMed ID: 23257741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Mono- and combination therapy with the mexidol in young patients with cerebral angiodystonia].
    Dyakonova EN; Makerova VV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(8):52-60. PubMed ID: 30251978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphotropic effect of dimephosphon, mexidol, and ketorolac is realized via activation of the lymphangion and stimulation of lymph formation.
    Khafiz'yanova RKh; Aleyeva GN; Mukhutdinov DA
    Bull Exp Biol Med; 2007 Apr; 143(4):446-8. PubMed ID: 18214296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Non pharmacotherapeutic correction of cerebral disturbances in children with diabetes mellitus type I].
    Filina NIu; Bolotova NV; Manukian VIu; Kompaniets OV; Raĭgorodskiĭ IuM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(12):66-70. PubMed ID: 20037524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mexidol in the post-surgery rehabilitation of patients with degenerative-dystrophic diseases of the spine].
    Shatrova VP; Meskhi KT
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(12):68-70. PubMed ID: 19253471
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of deficient cerebral circulation in selecting the treatment methods for patients with circulatory encephalopathy].
    Lushchyk UB
    Klin Khir (1962); 1993; (9-10):26-9. PubMed ID: 7908998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of mexidol on efficacy of traditional therapy of sick sinus syndrome in adolescents].
    Balykova LA
    Eksp Klin Farmakol; 2003; 66(5):25-7. PubMed ID: 14650210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of 3-hydroxypyridine derivatives on postischemic disorders in the autoregulatory reactions of the cerebral vessels].
    Pogorelyĭ VE; Arl't AV; Gaevyĭ MD; Smirnov LD; Gatsura VV
    Eksp Klin Farmakol; 1997; 60(4):22-4. PubMed ID: 9376750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The results of the study of the efficacy and safety of mexidol in patients with chronic cerebral ischemia].
    Chukanova EI; Chukanova AS; Mamayeva KI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(2):71-74. PubMed ID: 26081329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metabolic effects of mexidol in complex treatment of chronic brain ischemia].
    Demchenko EIu; Kulakova NV; Semiglazova TA; Golovacheva AB; Borodulina EV; Udut VV
    Eksp Klin Farmakol; 2008; 71(6):13-5. PubMed ID: 19140508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of mexidol, emoxypine, and dimephosphon on electrophysiological effects of nibentan].
    Kotliarov AA; Kurkina NV; Smirnova LE; Balykova LA
    Eksp Klin Farmakol; 2002; 65(2):27-30. PubMed ID: 12109287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy of the use of antioxidant preparation mexidol in comprehensive treatment of inflammatory diseases of parodontium].
    Garazha NN; Garus IaN; Ivashova AV; Sakuro AA
    Stomatologiia (Mosk); 2006; 85(6):19-21. PubMed ID: 17310943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.